Healthcare Distribution Alliance – Patients Move Us.
SEARCH
Site Search
Search Results For "Specialty Pharmaceutical Distribution"
Number Of Results : 15
2021 Specialty Pharmaceutical Distribution Facts, Figures and Trends
/resources/2021-specialty-pharmaceutical-distribution-facts-figures-and-trends
The 13th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceutical distribution offers insight into this unique marketplace.
/resources/2021-specialty-pharmaceutical-distribution-facts-figures-and-trends
The 13th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceutical distribution offers insight into this unique marketplace.
2022 Understanding Specialty Pharmaceutical Distribution
/resources/understanding-specialty-pharmaceutical-distribution
This interactive course is made up of nine modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the patient.
/resources/understanding-specialty-pharmaceutical-distribution
This interactive course is made up of nine modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the patient.
Center for Healthcare Supply Chain Research Releases Specialty Pharmaceutical Distribution: Facts, Figures and Trends
/news/2015-12-02-center-releases-specialty-trends
HDMA’s Center for Healthcare Supply Chain Research has published the latest edition of its annual benchmarking publication, Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2015 Edition). The seventh edition is sponsored by CuraScript Specialty Distribution; Genentech, A Member of the Roche Group; and Pharmacy First.
/news/2015-12-02-center-releases-specialty-trends
HDMA’s Center for Healthcare Supply Chain Research has published the latest edition of its annual benchmarking publication, Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2015 Edition). The seventh edition is sponsored by CuraScript Specialty Distribution; Genentech, A Member of the Roche Group; and Pharmacy First.
Annual Survey of HDA Specialty Pharmaceutical Distributors Reveals Rising Importance of Certain Therapeutic Areas
/news/2017-12-12-hda-research-foundation-releases-2017-specialty-pharmaceutical-distribution
Specialty pharmaceutical distributors expect products in the autoimmune/immune and ophthalmology categories to rise in importance over the next 12 months, followed by oncology, central nervous system and inflammatory products. The findings were published in the HDA Research Foundation’s 2017 edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends.
/news/2017-12-12-hda-research-foundation-releases-2017-specialty-pharmaceutical-distribution
Specialty pharmaceutical distributors expect products in the autoimmune/immune and ophthalmology categories to rise in importance over the next 12 months, followed by oncology, central nervous system and inflammatory products. The findings were published in the HDA Research Foundation’s 2017 edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends.
Hospitals Accounted for Nearly One-Third of Specialty Distributor Sales in 2015
/news/2016-12-21-foundation-releases-specialty-pharmaceutical-distribution
Sales to hospitals by specialty distributors significantly increased in 2015, according to new research by the HDA Research Foundation. As noted in Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2016 Edition), there was a seven percentage point increase in sales from specialty distributors to hospitals, climbing to 30 percent in 2015. Meanwhile, sales to independent physician-owned/-operated clinics continued to decrease from previous edition; these clinics captured 49 percent of specialty distributors’ sales.
/news/2016-12-21-foundation-releases-specialty-pharmaceutical-distribution
Sales to hospitals by specialty distributors significantly increased in 2015, according to new research by the HDA Research Foundation. As noted in Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2016 Edition), there was a seven percentage point increase in sales from specialty distributors to hospitals, climbing to 30 percent in 2015. Meanwhile, sales to independent physician-owned/-operated clinics continued to decrease from previous edition; these clinics captured 49 percent of specialty distributors’ sales.
Specialty Distributors Navigated Pandemic’s First Year To Reliably Deliver Lifesaving Medications
/news/2021-12-16-specialty-distributors-navigated-pandemics-first-year
Data published today by the Healthcare Distribution Alliance (HDA) Research Foundation indicate HDA-member specialty distributors adapted to ensure reliable delivery of complex medications during the first year of the COVID-19 response. As reported in the 2021 edition of Specialty Pharmaceutical Distribution Facts, Figures and Trends, individual specialty distributors serve as a critical nexus between 191 manufacturers and a record-high 50,000 healthcare provider ship-to points.
/news/2021-12-16-specialty-distributors-navigated-pandemics-first-year
Data published today by the Healthcare Distribution Alliance (HDA) Research Foundation indicate HDA-member specialty distributors adapted to ensure reliable delivery of complex medications during the first year of the COVID-19 response. As reported in the 2021 edition of Specialty Pharmaceutical Distribution Facts, Figures and Trends, individual specialty distributors serve as a critical nexus between 191 manufacturers and a record-high 50,000 healthcare provider ship-to points.
HDA Research Foundation Quantifies Efficiencies Provided by Specialty Rx Distributors
/news/2020-12-10-hda-foundation-quantifies-efficiencies-of-specialty-distribution
New data released by the HDA Research Foundation illustrate the continued supply chain efficiencies generated by HDA-member specialty distributors. According to the latest edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends, specialty distributors are a vital nexus between 176 manufacturers and more than 49,000 provider ship-to points for administration or dispensing to patients.
/news/2020-12-10-hda-foundation-quantifies-efficiencies-of-specialty-distribution
New data released by the HDA Research Foundation illustrate the continued supply chain efficiencies generated by HDA-member specialty distributors. According to the latest edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends, specialty distributors are a vital nexus between 176 manufacturers and more than 49,000 provider ship-to points for administration or dispensing to patients.
HDA Research Foundation Specialty Pharmaceutical Analysis Highlights Distributor Efficiencies Amid Evolving Market Dynamics
/news/2018-12-18-hda-research-foundation-releases-specialty-pharmaceutical-analysis
/news/2018-12-18-hda-research-foundation-releases-specialty-pharmaceutical-analysis
Analysis of Specialty Distributors Reveals Continued Growth
/news/2019-12-13-analysis-of-specialty-distributors-reveals-continued-growth
A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4 percent.
/news/2019-12-13-analysis-of-specialty-distributors-reveals-continued-growth
A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4 percent.
/news/2015-02-02-physicians-offices-and-clinics-are-largest-specialty-rx-customer
Physician’s offices and independently owned and operated physician clinics remain the largest customer base for specialty pharmaceutical distributors, at 63 percent of their sales value, according to the 2014 Specialty Pharmaceutical Distribution: Facts, Figures and Trends, published by HDMA’s Center for Healthcare Supply Chain Research.
Beyond Distribution: The Role of Hub Services
//www.hda.org/news/hda-blog/2020/01/29/15/05/2020-01-30-beyond-distribution-hub-services
The core mission of pharmaceutical distribution — secure, efficient and reliable healthcare delivery — provides more than 180 million patients across the United States with efficient and low-cost access to more than 4 billion prescription medicines each year. But distributors’ work does not end there.
//www.hda.org/news/hda-blog/2020/01/29/15/05/2020-01-30-beyond-distribution-hub-services
The core mission of pharmaceutical distribution — secure, efficient and reliable healthcare delivery — provides more than 180 million patients across the United States with efficient and low-cost access to more than 4 billion prescription medicines each year. But distributors’ work does not end there.
Number Of Results : 15
